By leading a new standard of maternity care, Biorithm aims to end preventable pregnancy complications & stillbirth through predictive and precision medicine. Forging new frontiers in women's health and pregnancy care to improve outcomes globally, we have developed cutting-edge analytic software together with medical-grade wearables for accurate monitoring of a wide range of pregnancy data. Founded by doctors & engineers, Biorithm is a medical technology company, spun off from Nanyang Technological University Singapore (NTU).
Location: Singapore
Employees: 11-50
Total raised: $3.5M
Founded date: 2016
Investors 1
| Date | Name | Website |
| - | SEEDS Capi... | seedscapit... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.12.2023 | Series A | $3.5M | - |
Mentions in press and media 7
| Date | Title | Description |
| 20.12.2023 | Deals in brief: Fikra Ace announces winners of accelerator program, Bayanat and Yahsat to merge into MENA’s space tech giant, multiple China and India deals, and more | Fikra Ace announces winners of its 2023 accelerator program To wrap up the 2023 edition of the Fikra Ace Accelerator program, a demo day was organized on November 9, 2023, by the Securities Commission Malaysia in collaboration with 1337 Ven... |
| 19.12.2023 | Deals in brief: Shopee buys credit arm of Brazil’s Blu, Biorithm and Blue Planet secure funding, multiple China and India deals, and more | Shopee buys Blu’s local credit arm to expand footprint in Brazil Shopee, one of the leading e-commerce companies in Southeast Asia, has bought the local credit arm of Blu, a Brazilian fintech company, according to The Business Times. The de... |
| 19.12.2023 | Biorithm raises USD 3.5 million in Series A funding | Massachusset, USA-based global women’s health medtech, Biorithm closed Series A financing with USD 3.5 million. Adaptive Capital Partners and SEEDS Capital led the financing for the company. The company announced the investment on December ... |
| 18.12.2023 | Biorithm Raises $3.5M in Series A Funding | Biorithm, a Singapore- Cambridge, MA-based women’s health medtech company, raised $3.5M in Series A funding. The round was led by Adaptive Capital Partners and SEEDS Capital. The company intends to use the funds to accelerate its expansion ... |
| 18.12.2023 | Biorithm Secures $3.5M in Series A Funding | CAMBRIDGE, MA, Biorithm has announced a $3.5M Series A Funding co-led by Adaptive Capital Partners and SEEDS Capital. >> Click here for more funding data on Biorithm >> To export Biorithm funding data to PDF and Excel, click... |
| 18.12.2023 | Biorithm Secures $3.5M to Revolutionize Connected Maternity Care | What You Should Know: – Biorithm, a global women’s health medtech company, has secured $3.5M in Series A funding to fuel its mission of improving maternal health outcomes and reducing preventable pregnancy complications. – This investment, ... |
| 18.12.2023 | Biorithm Secures $3.5 Million in Series A Funding to Advance Maternal Care Worldwide | New funds to fortify US market entry and growth strategy, as well as advance breakthrough research CAMBRIDGE, Mass., Dec. 18, 2023 /PRNewswire/ -- Biorithm, a global women's health medtech, has closed $3.5 million in Series A funding, co-le... |